Biosimilar App Notes & Case Studies
-
Reducing Plastic Waste Using Syringeless Filters
2/25/2026
A streamlined approach to HPLC sample preparation can cut plastic waste by up to 79%. Find out how reducing consumables simplifies workflows and supports more sustainable, efficient lab operations.
-
CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics
4/28/2025
CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.
-
Virus Retention Performance Under Diverse Processing Conditions
11/14/2025
Virus filtration is robust across a wide range of process parameters, including high protein concentration and flow decay. Discover how retention relies on size exclusion to simplify risk assessment.
-
Enhanced Flow Kit Performance With Leak And PUPSIT Testing
1/13/2026
Sterile drug filtration demands rigorous integrity testing to prevent contamination. Learn how PUPSIT and in situ leak testing strengthen compliance with EU GMP Annex 1 and ensure reliable manufacturing.
-
Optimizing Virus Bank Manufacturing
8/16/2024
Gain insight into two cases where clients were enabled to overcome obstacles during virus bank manufacturing.
-
Microbial Recovery And Flow Performance With Membranes
2/25/2026
Compare membrane materials and pore sizes to assess their impact on flow rate and microbial recovery. See how fast filtration and ≥90% organism recovery offer guidance for selecting reliable membranes.
-
Improving Bioprocess Monitoring And Control With Multivariate Data Analysis
12/9/2024
Learn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.
-
Selecting A Platform Filter For High Concentration mAbs
4/9/2025
Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.
-
Production Of A Highly Concentrated Monoclonal Antibody
10/4/2024
The production of a highly concentrated monoclonal antibody requires many process steps. Discover how to achieve a final mAb concentration above 200 g/L while maintaining critical quality attributes.
-
Optimization And Scale-Up Of A Plasmid DNA Production Process
9/30/2025
Optimizing pDNA production in E. coli requires strategic media selection and scale-up planning. Explore a study that identifies ideal conditions for high-yield manufacturing.